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Phototherapy motivates protein and lipid oxidation  
in jaundiced term and late term neonates  
 
Abstract: 
Background: Hyperbilirubinemia is one of the most important complications 
encountered in neonatal units. It has been proposed that phototherapy yields 
oxidative stress. Therefore, this study was undertaken to survey the levels of 
antioxidant and oxidative stress in the serum of neonates before and after 
phototherapy. 
Methods: This study was performed on thirty-five healthy, late preterm (>35 
weeks) and term newborns aged 6-10 days, who underwent phototherapy due to 
hyperbilirubinemia (>14.00 mg/dL). Infants with a congenital malformation, birth 
asphyxia, sepsis, signs and symptoms suggestive of severe illness, and receiving 
phototherapy before recruitment to the study were excluded. Blood samples were 
taken to determine total serum bilirubin, total antioxidant capacity (TAC) of serum, 
malondialdehyde (MDA), advanced oxidation protein products (AOPP) as markers 
of the intensity of oxidative stress and inflammation with photometric methods, 
reduced and oxidized glutathione (GSH) by HPLC-UV as well as the ratio of them 
before and after phototherapy.  
Results: TAC, GSH and bilirubin levels were significantly lower after 
phototherapy than before it, but reversely about levels of MDA, AOPP and 
oxidized GSH in addition to the ratio of reduced to oxidized GSH (p<0.05-0.001). 
AOPP and MDA showed a high negative correlation with bilirubin (respectively 
R=-0.985 and -0.986, p<0.001)) while vice versa about TAC and GSH (R=0.975 
and 0.988, P<0.001). 
Conclusion: Phototherapy induces oxidative stress and inflammation not only due 
to the elevation of protein and lipid oxidation but also with reducing of antioxidant 
markers of serum.  
Key Words: Phototherapy, Oxidative stress, Hyperbilirubinemia, Malondialdehyde, 
Advanced oxidation protein products  
 
 
 
 
 
 
Introduction: 
Bilirubin is a natural metabolic end-product of heme degradation. Bilirubin is an 
antioxidant at<6 mg/dL whereas it is responsible for oxidative stress and 
neurotoxicity at a higher level 
[1]
. Neonatal jaundice is clinically observed in 84% of 
term newborns 
[2] 
and is the most prevalent reason for hospital readmission in the 
neonatal period. Severe hyperbilirubinemia (serum bilirubin level of more than 20 
mg/dl) occurs in less than 2% of term infants and can lead to kernicterus and 
Permanent neurodevelopmental delay, as well as total serum bilirubin levels higher 
than 10 mg/dL, are presumed to be perilous for chromosomes 
[3, 4]
. Therefore, 
evaluating all infants for hyperbilirubinemia is important 
[5]
. Phototherapy is the 
most prevail treatment for lowering unconjugated bilirubin 
[6]
 although it may yield 
oxidative stress and mononuclear leukocyte DNA damage in jaundiced term 
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infants 
[7-9]
. Furthermore, antioxidant activity in the 
serum of neonates is lower than that of adults, and the 
neonatal erythrocyte membrane is more prone to 
oxidative damage thought its usual to pro-oxidant 
potential 
[10]
. Free radicals and lipid and protein 
peroxides as products of them may be responsible for 
the pathogenesis of many conditions such as retinopathy 
of prematurity, bronchopulmonary dysplasia, 
intracranial hemorrhage, periventricular leukomalacia, 
sepsis, necrotizing enterocolitis, and hypoxic ischemic 
encephalopathy 
[11]
. There are few and varying reports 
on changes of oxidative stress markers in serum of 
neonates with hyperbilirubinemia due to phototherapy 
[8, 10, 12]
. Therefore, this study was undertaken to survey 
the levels of antioxidant and oxidative stress in serum of 
jaundiced neonate by measuring of malondialdehyde 
(MDA) and advanced oxidation protein products 
(AOPP) respectively as markers of lipid and protein 
oxidation, serum total antioxidant capacity (TAC) and 
reduced and oxidized glutathione (GSH) as well as ratio 
of them before and after phototherapy.  
 
 
Materials: 
All materials were in analytical grade and purchased 
from Sigma or Merck Chemical Companies. 
Patients and samples 
The present cross-sectional study was carried out in the 
neonatal unit of the Madani Hospital of Khorramabad, 
Iran during October 2015 to March 2016. According to 
Morgan table, the sample size was estimated 35 
neonates (Confidence Level = 95%, Margin of Error = 
5%). This study was performed on thirty-five healthy, 
late preterm (> 35 weeks) and term newborn infants 
aged 6-10 days, who underwent phototherapy due to 
hyperbilirubinemia (> 14 mg/dL). Infants with a 
congenital malformation, birth asphyxia, sepsis, those 
with signs and symptoms suggestive of severe illness, 
and babies who had received phototherapy before 
recruitment to the study were excluded. Approval of the 
local research ethics committee was obtained for the 
study and informed consent was signed by the parents. 
These babies achieved 48-hour continuous phototherapy 
(450 nm, 13 μW/cm2/nm; MicroLite Phototherapy 
System, Draeger). Phototherapy was interrupted only 
for feeding, cleaning and blood sampling.  
Analytical methods 
Two blood samples with 2 ml volume were taken from 
a peripheral vein to determine total serum bilirubin, 
reduced and oxidized glutathione (GSH), TAC, MDA 
and AOPP prior and 48-h after phototherapy. Blood 
samples were centrifuged at 1500 × g for 10 minutes 
within 20 minutes of collection. Serum samples were 
stored at -80°C until testing.  
Total bilirubin was measured by the method of Doumas 
et al. 
[13]
, where bilirubin reacted with diazotized 
sulfanilic acid in the presence of caffeine with a final 
azo-pigment product. The developed color was read at 
546 nm. 
TAC was determined by the method of Benzie, et al. 
[14].
 
Briefly, a colorless ferric tripyridyltriazine complex is 
reduced to a blue ferrous complex by the antioxidants in 
the serum that modifying in absorbance at 593nm is 
directly correlated to the total reducing power in the 
sample. 
Level of malondialdehyde (MDA) in serum was 
measured by the thiobarbituric acid (TBA) assay 
[15]
.  
Determination of AOPP was based on the 
spectrophotometric detection, according to the method 
of Tylor, et al 
[16]
. Serum samples were diluted to 10% 
in PBS and 300 µL applied in triplicate to a 96-well 
microplate. Standards of chloramine T (300 µL; 0–100 
µM) were added to the plate and a sample blank was 
obtained by adding 300 µL PBS to the microplate. KI 
(1.16M, 15 µL) was added to all wells, followed 2min 
later by addition of 30 µL glacial acetic acid. The 
microplate was centrifuged (5800 g, 5min) to pellet 
precipitated protein, and 230 µL of the supernatant was 
transferred to a clean microplate. The absorption of the 
supernatant was read 10min at 340 nm after the addition 
of glacial acetic acid.  
Oxidized and reduced glutathione (GSSG and GSH) 
were analyzed HPLC- UV 
[17]
. 
Statistical analysis 
All data were expressed as mean ± S.D. The statistical 
analysis of the data was executed with the Statistical 
Package for the Social Sciences, version 16.0, for 
Windows (SPSS, Inc). The Student’s t-test for paired 
samples was used to compare the blood samples before 
and after phototherapy and Pearson rank correlation 
coefficient was used to compare the relationship 
between bilirubin with AOPP, MDA, GSH, and TAC 
using SPSS 16. P < 0.05 was considered significant.  
 
 
Results: 
This study comprised 35 infants (18 males and 17 
females), aged 6-10 days. Serum antioxidant/oxidant 
parameters and bilirubin before and after phototherapy 
are presented in Table .1. Bilirubin, TAC, and reduced 
GSH levels were significantly lower after phototherapy 
than before it. Reversely, MDA, AOPP and oxidized 
GSH concentrations were higher after phototherapy 
than before it. The ratio of reduced GSH to oxidized 
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GSH or GSH/GSSG is shown in Figure 1. The ratio of 
GSH/GSSG notable reduced after phototherapy in the 
jaundiced neonates (p<0.05-0.001). Figure 2 presented 
the correlation between bilirubin and other cited 
parameters. In this study, MDA and AOPP showed a 
high negative correlation with bilirubin (respectively, 
R=-0.985 and -0.986, p < 0.005) vice versa about TAC 
and GSH (R=0.975, 0.988 P<0.001). 
 
Table.1. Oxidative stress markers (MDA and AOPP) and Total antioxidant capacity of serum in the jaundiced 
neonates before and after phototherapy 
 
 
 
 
 
 
 
 
 
 
 
Fig 1. Ratio of reduced glutathione to oxidized of it (GSH/GSSG) in 
the jaundiced neonates before and after phototherapy 
a Indicates significance of data comparing before with after phototherapy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2. Correlation of advanced oxidation protein products (AOPP), malondialdehyde (MDA), the total 
antioxidant capacity of serum (TAC) and glutathione (GSH) with total bilirubin. 
Parameters 
Photography 
P value<A vs B 
Before (B) After (A) 
Bilirubin (mg/dL) 14.41±1.09 8.73±0.60 0.001 
MDA (µmol/L) 2.80±0.18 3.76±0.23 0.05 
AOPP (µmol/L) 206.54±11.76 290.13±15.85 0.001 
GSH (mmol/L)  1.94±0.12 1.27±0.07 0.05 
GSSG (µmol/L)  0.52±0.11 0.93±0.19 0.001 
TAC (µmol/L) 1.12±0.07 0.77±0.04 0.001 
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Discussion: 
In this study, phototherapy declined serum bilirubin 
along with multiplying AOPP and MDA in addition to 
the diminishing of the total antioxidant capacity of 
serum and the ratio of reduced GSH to its oxidized form 
(GSSG) (Table.1 & Fig.1). Further, it has not only 
subsided serum antioxidant level but also induced 
cellular injury following to protein and lipid oxidation 
(p<0.05-0.001). The effect of phototherapy on oxidized 
GSH in addition to the ratio of reduced GSH of its 
oxidized form, for the first time, has been reported by us 
as well as the effect on AOPP has been only reported in 
a survey performed before the present study 
[18]
.  
We selected ratio of GSH to GSSG and TAC as markers 
of antioxidants status of serum as well as AOPP and 
MDA as markers of oxidative stress for better 
investigation of the oxidative effect of phototherapy on 
the hyperbilirubinemia neonates. On the other hand, the 
levels of these markers exhibited the activity of the 
antioxidant enzyme. Based on our results, alternations 
of all antioxidative and oxidative stress markers without 
contradiction presented the oxidative effect of 
phototherapy on jaundiced neonates. Furthermore, there 
are some studies with controversial results between 
cited parameters 
[8, 10, 12]
. In accordance with our results, 
it was reported previously that phototherapy persuaded 
oxidative stress with the raising of MDA and AOPP as 
well as decreasing of GSH and superoxide dismutase 
(SOD) in erythrocytes and serum of neonatal jaundice  
[8, 18-20]
. Further, phototherapy in cultured cells induced 
the generation of more photo-oxidation products and 
caused more severe cellular damage in the presence of 
bilirubin 
[21]
. AOPP as markers of oxidative damages to 
proteins, the intensity of oxidative stress and 
inflammation 
[22]
. Furthermore, phototherapy prompted 
oxidative stress concomitant with inflammation that 
previous studies only reported its oxidative effect 
[8, 18, 
19]
. 
Based on Figure 2, a high negative correlation can be 
observed between oxidative stress markers (AOPP and 
MDA) and total bilirubin, but reverse about TAC and 
GSH (P<0.001). A similar result has been shown about 
the relation between bilirubin with MDA 
[23]
  and TAC. 
The correlation between bilirubin with AOPP and GSH 
has been reported to us for the first time. A notable 
positive correlation between bilirubin with TAS and 
GSH whereas inversely about MDA and AOPP, 
displaying that the bilirubin has a significant influence 
on the TAC and oxidative stress. However, no 
correlation was observed between total antioxidant 
capacity and serum total bilirubin in babies with a value 
greater than 20 mg/dL 
[12]
. Therefore, hyperbilirubi-
nemia may augment antioxidant defense in vivo 
[24]
. 
Phototherapy as widespread treatment for declining no-
direct bilirubin in jaundiced newborns induces cell 
injury not only with lipid and protein oxidation but also 
by generation of inflammatory events. It is suggested 
that pretreatment with antioxidants may reduce 
induction of oxidative stress due to phototherapy.  
The present data exhibit that phototherapy induces 
oxidative stress and inflammation not only due to the 
elevation of MDA and AOPP but also by reducing of 
TAS and the ratio of reduced GSH to its oxidized form. 
It is suggested that supplementation of antioxidants 
before phototherapy may reduce oxidative stress. A 
high positive correlation of GSH and TAS with total 
bilirubin, but reversely AOPP and MDA presented that 
bilirubin level has an important effect on the TAC and 
oxidative stress. 
 
 
The limitations of the study: 
The limitations of the study were that a) the study 
was managed only on preterm and term infants who 
needed phototherapy without a control group b) 
antioxidative and oxidative markers were just 
determined 48 hours after phototherapy. 
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